| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/02/2013 | EP2540301A2 Methods and pharmaceutical compositions for healing wounds |
| 01/02/2013 | EP2540283A1 Improved botulinum toxin compositions |
| 01/02/2013 | EP2539715A1 Methods for preparing peg-hemoglobin conjugates using reduced reactant ratios |
| 01/02/2013 | EP2539448A1 Protein c zymogen and methods of use thereof to prevent cancer metastases |
| 01/02/2013 | EP2539443A1 Methods and compositions for enhancing fat graft survival |
| 01/02/2013 | EP2539439A1 Modulation of angiogenesis |
| 01/02/2013 | EP2539364A1 Peptides for treatment of obesity |
| 01/02/2013 | EP2538968A1 Process for production and purification of recombinant lysosomal alpha-mannosidase |
| 01/02/2013 | EP2538967A1 Stable compositions of factor ix |
| 01/02/2013 | EP2538966A1 Long-acting insulin analogue preparations in soluble and crystalline forms |
| 01/02/2013 | EP2538965A1 Therapeutic compositions for the treatment of dry eye disease |
| 01/02/2013 | EP2538964A1 Modulation of cytokine-induced chronic inflammatory responses |
| 01/02/2013 | EP2538963A1 Method of treatment or prevention of hair loss or for the enhancement of hair growth |
| 01/02/2013 | EP2538962A1 Use of transforming growth factor - beta 1 (tgf- 1) inhibitor peptides for the treatment of corneal fibrosis and/or haze |
| 01/02/2013 | EP2538961A2 Methods for inhibiting necrosis |
| 01/02/2013 | EP2538960A1 Surfactant composition |
| 01/02/2013 | EP2538959A1 Compounds for the treatment of inflammation and neutropenia |
| 01/02/2013 | EP2538958A1 Mitochondrial-targeted antioxidants protect against mechanical ventilation-induced diaphragm dysfunction and skeletal muscle atrophy |
| 01/02/2013 | EP2538957A2 Car peptide for homing, diagnosis,&targeted therapy for pulmonary and fibrotic disorders |
| 01/02/2013 | EP2538956A1 Methods and compositions to treat hemorrhagic conditions of the brain |
| 01/02/2013 | EP2538955A2 Pharmaceutical or neutraceutical formulation |
| 01/02/2013 | EP2479193A9 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof |
| 01/02/2013 | EP1598422B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
| 01/02/2013 | CN1886148B Selective inhibition of NF-kB activation by peptides designed to disrupt NEMO oligomerization |
| 01/02/2013 | CN102859364A Methods for preparing peg-hemoglobin conjugates using reduced reactant ratios |
| 01/02/2013 | CN102858978A High-purity soluble thrombomodulin and method for producing same |
| 01/02/2013 | CN102858964A Polypeptides |
| 01/02/2013 | CN102858795A Use of proteases for gluten intolerance |
| 01/02/2013 | CN102858364A Therapeutic peptide composition and method |
| 01/02/2013 | CN102858363A HB-EGF composition and use thereof to treat a condition associated with enhanced urothelium permeability |
| 01/02/2013 | CN102858362A SPARC angiogenic domain and methods of use |
| 01/02/2013 | CN102858361A Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| 01/02/2013 | CN102858360A Methods for treating diabetic foot ulcers |
| 01/02/2013 | CN102858356A Antibacterial auxiliary agent comprising kombu extract as active ingredient, antibacterial composition, and food or beverage |
| 01/02/2013 | CN102851315A Application of recombinant adenovirus TMEM166 as gene therapeutic drug in inhibiting tumor |
| 01/02/2013 | CN102851296A Anti-liver cancer protein pp3501, its preparation method and application |
| 01/02/2013 | CN102851264A An apyrase encoding gene of Aedes albopictus, and preparation method and application of protein thereof |
| 01/02/2013 | CN102851259A Preparation method of antioxidant |
| 01/02/2013 | CN102850458A Novel recombined dual-function fusion protein and its preparation method and application |
| 01/02/2013 | CN102850451A Recombinant textilinin-1 with plasmin inhibition activity, and preparation method and application thereof |
| 01/02/2013 | CN102850443A Integrin blocker polypeptides and application thereof |
| 01/02/2013 | CN102850436A Growth hormone releasing peptides |
| 01/02/2013 | CN102850431A Chimeric peptide based on opioid peptide Biphalin and neuropeptide FF, its synthesis and application |
| 01/02/2013 | CN102850430A Animal colostrum derived protein fragment and application thereof |
| 01/02/2013 | CN102847159A A glucose metabolism enhancer |
| 01/02/2013 | CN102847142A Oral biological medicine used for treating chemotherapy and radiotherapy syndromes, and preparation method thereof |
| 01/02/2013 | CN102847141A Oral formulations for enteric disorders and/or rehydration |
| 01/02/2013 | CN102847140A Application of gastrin in anion exchangers 2 |
| 01/02/2013 | CN102847139A Applications of basic fibroblast growth factor in preparation of drugs for treatment of spinal cord injuries |
| 01/02/2013 | CN102847138A Medicine composition containing muscular amino acid and nucleoside compound and preparation method thereof |
| 01/02/2013 | CN102847137A Medicinal application of angiostatin |
| 01/02/2013 | CN102847136A Composition for enzyme inhibition |
| 01/02/2013 | CN102847135A Medicine for reinforcing lymph cycle power to radically cure filarial chyluria, and its use method |
| 01/02/2013 | CN102847134A Preparation method for chlorella polypeptide microcapsule |
| 01/02/2013 | CN102846663A Intravenous drip type body fluid replenisher |
| 01/02/2013 | CN102846662A Oral body fluid replenisher |
| 01/02/2013 | CN102846553A Preparation method for chlorella polypeptide-chitosan nanoparticle |
| 01/02/2013 | CN102846456A Skin scraper with skin care liquid |
| 01/02/2013 | CN102845422A Antimicrobial compositions and methods |
| 01/02/2013 | CN102228679B Chicken interferon gamma combined medicament and application |
| 01/02/2013 | CN102225195B Porcine interferon-gamma composite medicament and application thereof |
| 01/02/2013 | CN102198272B Medicinal composition for promoting fracture union and repairing injured nerves |
| 01/02/2013 | CN102178929B Application of ancylostoma caninum anticoagulant peptide (AcAP) and recombinant thereof in preparation of thrombus dissolving medicaments |
| 01/02/2013 | CN102070704B Entire gene sequence of severe fever with thrombocytopenia syndrome virus (SFTSV) and application |
| 01/02/2013 | CN101935669B Detoxication engineering bacteria, and preparation method and application thereof |
| 01/02/2013 | CN101874895B Application of CART (Cocaine Amphetamine Regulated Transcript) in preparing medicaments for treating alzheimers diseases |
| 01/02/2013 | CN101824090B Monoclonal antibody hpam4 |
| 01/02/2013 | CN101820917B Aqueous ophthalmic formulations |
| 01/02/2013 | CN101799476B Reagent box for sieving autoantibody for tsh receptor |
| 01/02/2013 | CN101772351B A novel bone mass increasing agent |
| 01/02/2013 | CN101671388B Blood brain barrier penetrable erythropoietin (EPO) and application thereof |
| 01/02/2013 | CN101600452B Pharmaceutical composition containing arazyme for the prevention of liver dysfunction |
| 01/02/2013 | CN101553244B Treatment for intimal hyperplasia and related conditions |
| 01/02/2013 | CN101432012B Pharmaceutical combination for the treatment and or chemosensibilization of refractory tumors to anticancer drugs |
| 01/02/2013 | CN101400692B Potent compstatin analogs |
| 01/02/2013 | CN101351190B Sodium chloride solution for drug reconstitution or dilution |
| 01/02/2013 | CN101298478B Method for detecting and purifying CD8+T lymphocyte populations, specific of peptides present in context of hla |
| 01/02/2013 | CN101170994B 荷电的脂蛋白络合物及其用途 Charged lipoprotein complexes and their use |
| 01/02/2013 | CN101137349B Controlled release compositions for interferon based on PEGT/PBT block copolymers |
| 01/01/2013 | US8344110 Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof |
| 01/01/2013 | US8344106 Collagen mixture and method of making the same |
| 01/01/2013 | US8344102 Nanoparticle and magnetic resonance imaging contrast agent |
| 01/01/2013 | US8344101 Composition for improving brain function and method for improving brain function |
| 01/01/2013 | US8344100 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
| 01/01/2013 | US8343933 Variants derived from ActRIIB and uses therefor |
| 01/01/2013 | US8343932 Protease-sensitive site in apolipoprotein A1, therapeutic and diagnostic implications |
| 01/01/2013 | US8343930 Combination therapy for the treatment of tumors |
| 01/01/2013 | US8343929 Treating neoplasms with neurotoxin |
| 01/01/2013 | US8343928 Monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminus |
| 01/01/2013 | US8343927 Pharmaceutical compositions for prevention of overdose or abuse |
| 01/01/2013 | US8343926 Therapeutic strategies for prevention and treatment of alzheimer's disease |
| 01/01/2013 | US8343925 Composition for improving brain function and method for improving brain function |
| 01/01/2013 | US8343924 Composition for improving brain function and method for improving brain function |
| 01/01/2013 | US8343923 Use of notch signaling regulators for modulating osteogenesis |
| 01/01/2013 | US8343922 Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells |
| 01/01/2013 | US8343921 Method for treating myocardial ischemia |
| 01/01/2013 | US8343920 Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds |
| 01/01/2013 | US8343919 Cancer treatment using natriuretic peptides |
| 01/01/2013 | US8343918 Stabilized insulin-like growth factor polypeptides |
| 01/01/2013 | US8343917 Combination of erythropoietin glycoisoforms |